Testosterone and the aging male.
The number and magnitude of studies involving testosterone-supplementation therapy in older men are limited. In addition, many studies to date have not been blinded or controlled, were reported in abstract form only, and had involved a variety of androgen-replacement regimens and outcomes measurements. Nonetheless, an overview of the data suggests there is real potential for supplementation therapy to improve bone mass and muscle mass and strength in this age group. Affects on mood, sexual function, and cognition are less clear but may be meaningful in certain men. Questions still remain, however, on the magnitude and longevity of the beneficial effects of testosterone supplementation in the older man and whether only certain subgroups of men would truly benefit from therapy. More importantly, the long-term risks of androgen therapy in this age group really are not known, especially in the areas of cardiovascular disease and prostate diseases. Presently, men who use androgen-supplementation therapy for age-related "testosterone deficiency" should consider this as a gamble.
Tenover
J L
JL
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
D000339:Affect; D000375:Aging / Q000502:physiology*; D000728:Androgens / Q000627:therapeutic use*; D015519:Bone Density; D003071:Cognition; D006801:Humans; D008297:Male; D024510:Muscle Development; D018482:Muscle, Skeletal / Q000254:growth & development; D012725:Sexual Behavior; D013739:Testosterone / Q000097:blood / Q000502:physiology* / Q000627:therapeutic use
D000728:Androgens; D013739:Testosterone